US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ZyVersa Therapeutics, Inc.

0.1600

-0.0200-11.11%

Volume:126.62K

Turnover:22.71K

Market Cap:1.30M

PE:-0.03

High:0.2000

Open:0.1800

Low:0.1600

Close:0.1800

52wk High:1.94

52wk Low:0.1100

Shares:8.10M

Float Shares:7.67M

Volume Ratio:2.54

T/O Rate:1.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.6800

EPS(LYR):-8.4803

ROE:-112.65%

ROA:-46.30%

PB:-0.11

PE(LYR):-0.02

Loading ...

Overview Company News Filings

ZyVersa Therapeutics Director Robert Finizio Resigns

ZyVersa Therapeutics posts $20.7 million pre-tax loss for Q3 2025

ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

Zyversa Therapeutics Delays Quarterly Financial Filing

ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes

ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression

Zyversa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-Term Value-Building Milestones

THOMSON REUTERS

ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones

ZyVersa Therapeutics Inc. Secures Approval for OTCQB Listing, Set to Begin Trading on July 28, 2025

Zyversa Therapeutics Faces Nasdaq Delisting Due to Failure to Meet Minimum Bid Price Requirements

Zyversa Therapeutics Inc. Enters Warrant Exercise Inducement Agreement for 3.06M Shares, Plans to Register Inducement Warrant Shares

ZyVersa Therapeutics Initiates New Clinical Study for Cholesterol Efflux Mediator VAR 200 to Combat Chronic Kidney Diseases

BRIEF-ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million

Zyversa Therapeutics Inc. Conducted Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ZVSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZVSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","market":"US","secType":"STK","nameCN":"ZyVersa Therapeutics, Inc.","latestPrice":0.16,"timestamp":1770411600000,"preClose":0.18,"halted":0,"volume":126624,"delay":15,"changeRate":-0.11111111111111106,"floatShares":7673206,"shares":8095921,"eps":-4.68,"marketStatus":"Market Closed","change":-0.02,"latestTime":"02-06 16:00:00 EST Delay","open":0.18,"high":0.2,"low":0.16,"amount":22709.791,"amplitude":0.222222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-4.68,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.18,"volumeRatio":2.535928867824914},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZVSA\",,,,,undefined,":{"symbol":"ZVSA","floatShares":7673206,"roa":"-46.30%","roe":"-112.65%","lyrEps":-8.480319,"volumeRatio":2.535928867824914,"shares":8095921,"dividePrice":0,"high":0.2,"amplitude":0.222222,"preClose":0.18,"low":0.16,"week52Low":0.11,"pbRate":"-0.11","week52High":1.94,"institutionHeld":0,"latestPrice":0.16,"eps":-4.68,"divideRate":0,"volume":126624,"delay":15,"ttmEps":-4.68,"open":0.18,"prevYearClose":0.1336,"prevWeekClose":0.16,"prevMonthClose":0.16,"prevQuarterClose":0.1336,"fiveDayClose":0.16,"twentyDayClose":0.1603,"sixtyDayClose":0.1419},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZVSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-17","symbol":"ZVSA","reason":null,"defaultRemindTime":1752759000000,"announcedDate":"2025-07-16","type":"delisting","dateTimestamp":1752724800000},{"market":"US","date":"2025-05-12","symbol":"ZVSA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.73},{"date":"2025-03-27","symbol":"ZVSA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-Market","dateTimestamp":1743048000000,"actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ZVSA","fiscalQuarterEnding":"2024/09","expectedEps":-5.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-2.43},{"market":"US","date":"2024-08-09","symbol":"ZVSA","fiscalQuarterEnding":"2024/06","expectedEps":-5.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-3.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZVSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZVSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZVSA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZVSA","date":"2025-07-16","current":-0.302538,"percent":0.481258,"low":-21.281928,"twenty":-7.733869,"median":-0.246413,"eighty":-0.055543,"high":-0.009885,"avg":-2.550237,"sd":3.834209,"marketCap":2675531},"quantilePoints":[{"date":"2022-02-11","current":-7.527467,"twenty":-7.527467,"median":-7.527467,"eighty":-7.527467,"marketCap":95472110},{"date":"2022-02-18","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-02-25","current":-7.542751,"twenty":-7.542751,"median":-7.542751,"eighty":-7.527467,"marketCap":95665962},{"date":"2022-03-04","current":-7.535109,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95569036},{"date":"2022-03-11","current":-7.550393,"twenty":-7.542751,"median":-7.542751,"eighty":-7.535109,"marketCap":95762888},{"date":"2022-03-18","current":-7.565677,"twenty":-7.550393,"median":-7.542751,"eighty":-7.535109,"marketCap":95956740},{"date":"2022-03-25","current":-7.603888,"twenty":-7.550393,"median":-7.542751,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-01","current":-7.603888,"twenty":-7.565677,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-08","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-14","current":-7.603888,"twenty":-7.603888,"median":-7.550393,"eighty":-7.542751,"marketCap":96441370},{"date":"2022-04-22","current":-7.852153,"twenty":-7.603888,"median":-7.558035,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-04-29","current":-7.860061,"twenty":-7.603888,"median":-7.565677,"eighty":-7.542751,"marketCap":99690456},{"date":"2022-05-06","current":-7.867968,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99790748},{"date":"2022-05-13","current":-7.836338,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99389580},{"date":"2022-05-20","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-05-27","current":-7.852153,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99590164},{"date":"2022-06-03","current":-7.875876,"twenty":-7.860061,"median":-7.603888,"eighty":-7.542751,"marketCap":99891041},{"date":"2022-06-10","current":-7.875876,"twenty":-7.867968,"median":-7.603888,"eighty":-7.547336,"marketCap":99891041},{"date":"2022-06-17","current":-7.836338,"twenty":-7.867968,"median":-7.603888,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-06-24","current":-7.875876,"twenty":-7.867968,"median":-7.820523,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-01","current":-7.836338,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99389580},{"date":"2022-07-08","current":-7.860061,"twenty":-7.867968,"median":-7.836338,"eighty":-7.550393,"marketCap":99690456},{"date":"2022-07-15","current":-7.875876,"twenty":-7.867968,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-22","current":-7.875876,"twenty":-7.874294,"median":-7.844246,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-07-29","current":-7.875876,"twenty":-7.875876,"median":-7.850967,"eighty":-7.550393,"marketCap":99891041},{"date":"2022-08-05","current":-7.891691,"twenty":-7.875876,"median":-7.852153,"eighty":-7.55345,"marketCap":100091625},{"date":"2022-08-12","current":-10.347355,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100292210},{"date":"2022-08-19","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-08-26","current":-10.337007,"twenty":-7.875876,"median":-7.852153,"eighty":-7.565677,"marketCap":100191917},{"date":"2022-09-02","current":-10.32666,"twenty":-7.875876,"median":-7.852153,"eighty":-7.573319,"marketCap":100091625},{"date":"2022-09-09","current":-10.347355,"twenty":-7.883783,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-09-16","current":-10.316312,"twenty":-7.891691,"median":-7.860061,"eighty":-7.603888,"marketCap":99991333},{"date":"2022-09-23","current":-10.357702,"twenty":-7.907506,"median":-7.860061,"eighty":-7.603888,"marketCap":100392502},{"date":"2022-09-30","current":-10.434782,"twenty":-10.316312,"median":-7.860061,"eighty":-7.603888,"marketCap":100191917},{"date":"2022-10-07","current":-10.445227,"twenty":-10.32666,"median":-7.860061,"eighty":-7.603888,"marketCap":100292210},{"date":"2022-10-14","current":-10.476563,"twenty":-10.32666,"median":-7.867968,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-10-21","current":-10.497453,"twenty":-10.337007,"median":-7.867968,"eighty":-7.603888,"marketCap":100793671},{"date":"2022-10-28","current":-10.476563,"twenty":-10.337007,"median":-7.875876,"eighty":-7.603888,"marketCap":100593086},{"date":"2022-11-04","current":-10.507899,"twenty":-10.347355,"median":-7.875876,"eighty":-7.603888,"marketCap":100893963},{"date":"2022-11-11","current":-10.539234,"twenty":-10.357702,"median":-7.875876,"eighty":-7.603888,"marketCap":101194839},{"date":"2022-11-18","current":-10.586238,"twenty":-10.378397,"median":-7.875876,"eighty":-7.603888,"marketCap":101646154},{"date":"2022-11-25","current":-10.643686,"twenty":-10.434782,"median":-7.875876,"eighty":-7.603888,"marketCap":102197761},{"date":"2022-12-02","current":-10.654132,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":102298054},{"date":"2022-12-09","current":-10.121425,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":97183151},{"date":"2022-12-16","current":-2.562,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":29243788},{"date":"2022-12-23","current":-1.710652,"twenty":-10.466118,"median":-7.875876,"eighty":-7.603888,"marketCap":19526132},{"date":"2022-12-30","current":-1.249174,"twenty":-10.453583,"median":-7.875876,"eighty":-7.603888,"marketCap":14258617},{"date":"2023-01-06","current":-1.281,"twenty":-10.441049,"median":-7.875876,"eighty":-7.580961,"marketCap":14621894},{"date":"2023-01-13","current":-2.752956,"twenty":-10.434782,"median":-7.875876,"eighty":-7.556507,"marketCap":31423450},{"date":"2023-01-20","current":-1.718609,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19616951},{"date":"2023-01-27","current":-1.670869,"twenty":-10.434782,"median":-7.875876,"eighty":-7.550393,"marketCap":19072036},{"date":"2023-02-03","current":-1.933435,"twenty":-10.434782,"median":-7.867968,"eighty":-7.542751,"marketCap":22069070},{"date":"2023-02-10","current":-1.607217,"twenty":-10.424337,"median":-7.867968,"eighty":-7.542751,"marketCap":18345482},{"date":"2023-02-17","current":-1.869782,"twenty":-10.381724,"median":-7.860061,"eighty":-7.536637,"marketCap":21342516},{"date":"2023-02-24","current":-1.702696,"twenty":-10.378397,"median":-7.860061,"eighty":-7.527467,"marketCap":19435313},{"date":"2023-03-03","current":-1.654956,"twenty":-10.357702,"median":-7.860061,"eighty":-4.265844,"marketCap":18890397},{"date":"2023-03-10","current":-1.670869,"twenty":-10.357702,"median":-7.860061,"eighty":-2.418782,"marketCap":19072036},{"date":"2023-03-17","current":-1.400348,"twenty":-10.357702,"median":-7.860061,"eighty":-2.060739,"marketCap":15984182},{"date":"2023-03-24","current":-1.734522,"twenty":-10.357702,"median":-7.852153,"eighty":-1.958179,"marketCap":19798589},{"date":"2023-03-31","current":-1.535609,"twenty":-10.357702,"median":-7.852153,"eighty":-1.869782,"marketCap":17528109},{"date":"2023-04-06","current":-1.400348,"twenty":-10.351494,"median":-7.852153,"eighty":-1.858643,"marketCap":15984182},{"date":"2023-04-14","current":-1.154538,"twenty":-10.347355,"median":-7.852153,"eighty":-1.802948,"marketCap":16305101},{"date":"2023-04-21","current":-1.141492,"twenty":-10.347355,"median":-7.852153,"eighty":-1.755336,"marketCap":16120863},{"date":"2023-04-28","current":-0.327576,"twenty":-10.347355,"median":-7.850967,"eighty":-1.734569,"marketCap":4626227},{"date":"2023-05-05","current":-0.37167,"twenty":-10.347355,"median":-7.844246,"eighty":-1.722141,"marketCap":5248953},{"date":"2023-05-12","current":-0.323359,"twenty":-10.347355,"median":-7.844246,"eighty":-1.702696,"marketCap":4566681},{"date":"2023-05-19","current":-0.244626,"twenty":-10.341146,"median":-7.836338,"eighty":-1.670869,"marketCap":3404726},{"date":"2023-05-26","current":-0.271366,"twenty":-10.337007,"median":-7.836338,"eighty":-1.65973,"marketCap":3776888},{"date":"2023-06-02","current":-0.595797,"twenty":-10.337007,"median":-7.82843,"eighty":-1.607217,"marketCap":8292357},{"date":"2023-06-09","current":-0.579813,"twenty":-10.337007,"median":-7.820523,"eighty":-1.591304,"marketCap":8069879},{"date":"2023-06-16","current":-0.561146,"twenty":-10.337007,"median":-7.603888,"eighty":-1.559478,"marketCap":7810081},{"date":"2023-06-23","current":-0.440415,"twenty":-10.337007,"median":-7.603888,"eighty":-1.529243,"marketCap":6129730},{"date":"2023-06-30","current":-0.430212,"twenty":-10.337007,"median":-7.603888,"eighty":-1.457635,"marketCap":5987729},{"date":"2023-07-07","current":-0.408107,"twenty":-10.332868,"median":-7.603888,"eighty":-1.400348,"marketCap":5680059},{"date":"2023-07-14","current":-0.425111,"twenty":-10.32666,"median":-7.603888,"eighty":-1.296913,"marketCap":5916728},{"date":"2023-07-21","current":-0.368996,"twenty":-10.32666,"median":-7.603888,"eighty":-1.261904,"marketCap":5135720},{"date":"2023-07-28","current":-0.313371,"twenty":-10.32666,"median":-7.603888,"eighty":-1.163669,"marketCap":4361521},{"date":"2023-08-04","current":-0.309309,"twenty":-10.32666,"median":-7.565677,"eighty":-1.141492,"marketCap":4304983},{"date":"2023-08-11","current":-0.307181,"twenty":-10.32666,"median":-7.558035,"eighty":-1.11801,"marketCap":4275368},{"date":"2023-08-18","current":-0.303699,"twenty":-10.32666,"median":-7.550393,"eighty":-1.058,"marketCap":4226907},{"date":"2023-08-25","current":-0.051589,"twenty":-10.32666,"median":-7.550393,"eighty":-0.57554,"marketCap":4665022},{"date":"2023-09-01","current":-0.048582,"twenty":-10.32666,"median":-7.550393,"eighty":-0.562665,"marketCap":4393153},{"date":"2023-09-08","current":-0.041989,"twenty":-10.32666,"median":-7.542751,"eighty":-0.558863,"marketCap":3796895},{"date":"2023-09-15","current":-0.060169,"twenty":-10.320451,"median":-7.542751,"eighty":-0.517114,"marketCap":5440931},{"date":"2023-09-22","current":-0.052281,"twenty":-10.316312,"median":-7.542751,"eighty":-0.441231,"marketCap":4727605},{"date":"2023-09-29","current":-0.060153,"twenty":-10.303896,"median":-7.542751,"eighty":-0.431743,"marketCap":5439425},{"date":"2023-10-06","current":-0.062896,"twenty":-10.295618,"median":-7.542751,"eighty":-0.424227,"marketCap":5687462},{"date":"2023-10-13","current":-0.06304,"twenty":-10.253773,"median":-7.535109,"eighty":-0.407903,"marketCap":5700517},{"date":"2023-10-20","current":-0.061644,"twenty":-10.163206,"median":-7.527467,"eighty":-0.38615,"marketCap":5574322},{"date":"2023-10-27","current":-0.055581,"twenty":-10.142315,"median":-7.523646,"eighty":-0.376992,"marketCap":5026028},{"date":"2023-11-03","current":-0.046534,"twenty":-8.35029,"median":-4.265844,"eighty":-0.362186,"marketCap":4207939},{"date":"2023-11-10","current":-0.035803,"twenty":-7.907506,"median":-2.657478,"eighty":-0.333478,"marketCap":3237545},{"date":"2023-11-17","current":-0.036701,"twenty":-7.907506,"median":-2.17213,"eighty":-0.328592,"marketCap":3289764},{"date":"2023-11-24","current":-0.040004,"twenty":-7.907506,"median":-2.068696,"eighty":-0.324245,"marketCap":3585846},{"date":"2023-12-01","current":-0.031557,"twenty":-7.898017,"median":-2.024935,"eighty":-0.316333,"marketCap":2828641},{"date":"2023-12-08","current":-0.015952,"twenty":-7.891691,"median":-1.958179,"eighty":-0.309502,"marketCap":1429861},{"date":"2023-12-15","current":-0.01023,"twenty":-7.891691,"median":-1.901609,"eighty":-0.307413,"marketCap":916976},{"date":"2023-12-22","current":-0.048692,"twenty":-7.886946,"median":-1.861826,"eighty":-0.30211,"marketCap":4364571},{"date":"2023-12-29","current":-0.055512,"twenty":-7.883783,"median":-1.857848,"eighty":-0.290163,"marketCap":4975946},{"date":"2024-01-05","current":-0.052962,"twenty":-7.883783,"median":-1.853869,"eighty":-0.285597,"marketCap":4747336},{"date":"2024-01-12","current":-0.047393,"twenty":-7.883783,"median":-1.802152,"eighty":-0.251536,"marketCap":4248168},{"date":"2024-01-19","current":-0.034922,"twenty":-7.879039,"median":-1.770326,"eighty":-0.072424,"marketCap":3130284},{"date":"2024-01-26","current":-0.038707,"twenty":-7.875876,"median":-1.750753,"eighty":-0.065177,"marketCap":3469529},{"date":"2024-02-02","current":-0.034243,"twenty":-7.875876,"median":-1.742518,"eighty":-0.062982,"marketCap":3069461},{"date":"2024-02-09","current":-0.03412,"twenty":-7.875876,"median":-1.734522,"eighty":-0.061606,"marketCap":3058450},{"date":"2024-02-16","current":-0.03374,"twenty":-7.875876,"median":-1.721553,"eighty":-0.060163,"marketCap":3024368},{"date":"2024-02-23","current":-0.036285,"twenty":-7.875876,"median":-1.710652,"eighty":-0.059241,"marketCap":3252454},{"date":"2024-03-01","current":-0.064345,"twenty":-7.875876,"median":-1.702696,"eighty":-0.0586,"marketCap":5767693},{"date":"2024-03-08","current":-0.080782,"twenty":-7.875876,"median":-1.674847,"eighty":-0.059241,"marketCap":7241014},{"date":"2024-03-15","current":-0.06769,"twenty":-7.875876,"median":-1.670869,"eighty":-0.060042,"marketCap":6067487},{"date":"2024-03-22","current":-0.069477,"twenty":-7.875876,"median":-1.658934,"eighty":-0.060153,"marketCap":6227737},{"date":"2024-03-28","current":-0.060072,"twenty":-7.875876,"median":-1.619152,"eighty":-0.060088,"marketCap":5904958},{"date":"2024-04-05","current":-0.057206,"twenty":-7.875876,"median":-1.599261,"eighty":-0.058057,"marketCap":5623190},{"date":"2024-04-12","current":-0.057947,"twenty":-7.875876,"median":-1.591304,"eighty":-0.057773,"marketCap":5696100},{"date":"2024-04-19","current":-0.048367,"twenty":-7.875876,"median":-1.559478,"eighty":-0.05663,"marketCap":4754345},{"date":"2024-04-26","current":-0.046937,"twenty":-7.875876,"median":-1.533619,"eighty":-0.055531,"marketCap":4613841},{"date":"2024-05-03","current":-0.044349,"twenty":-7.875876,"median":-1.495826,"eighty":-0.054896,"marketCap":4359415},{"date":"2024-05-10","current":-0.040795,"twenty":-7.875876,"median":-1.424376,"eighty":-0.05319,"marketCap":4010054},{"date":"2024-05-17","current":-0.037826,"twenty":-7.875876,"median":-1.400348,"eighty":-0.051973,"marketCap":3691072},{"date":"2024-05-24","current":-0.03339,"twenty":-7.875876,"median":-1.308848,"eighty":-0.051476,"marketCap":3258245},{"date":"2024-05-31","current":-0.031755,"twenty":-7.875876,"median":-1.292934,"eighty":-0.050906,"marketCap":3098678},{"date":"2024-06-07","current":-0.03697,"twenty":-7.875876,"median":-1.281,"eighty":-0.049989,"marketCap":3607530},{"date":"2024-06-14","current":-0.041742,"twenty":-7.875876,"median":-1.23334,"eighty":-0.049025,"marketCap":4073207},{"date":"2024-06-21","current":-0.041325,"twenty":-7.875876,"median":-1.167583,"eighty":-0.048602,"marketCap":4032547},{"date":"2024-06-28","current":-0.030973,"twenty":-7.875876,"median":-1.16106,"eighty":-0.048367,"marketCap":3022323},{"date":"2024-07-05","current":-0.030887,"twenty":-7.875876,"median":-1.141492,"eighty":-0.047431,"marketCap":3013974},{"date":"2024-07-12","current":-0.043208,"twenty":-7.875876,"median":-1.134969,"eighty":-0.046921,"marketCap":4216224},{"date":"2024-07-15","current":-0.041924,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046855,"marketCap":4090990},{"date":"2024-08-02","current":-0.029261,"twenty":-7.875876,"median":-1.128446,"eighty":-0.046715,"marketCap":2855344},{"date":"2024-08-09","current":-0.025753,"twenty":-7.875876,"median":-1.108878,"eighty":-0.04506,"marketCap":2513036},{"date":"2024-08-16","current":-0.142372,"twenty":-7.875876,"median":-1.069741,"eighty":-0.045348,"marketCap":3108171},{"date":"2024-08-23","current":-0.142372,"twenty":-7.874294,"median":-0.579813,"eighty":-0.045816,"marketCap":3108171},{"date":"2024-08-30","current":-0.130115,"twenty":-7.867968,"median":-0.574291,"eighty":-0.046563,"marketCap":2840580},{"date":"2024-09-06","current":-0.132,"twenty":-7.867968,"median":-0.567606,"eighty":-0.04668,"marketCap":2881748},{"date":"2024-09-13","current":-0.105129,"twenty":-7.867968,"median":-0.561146,"eighty":-0.046855,"marketCap":2295107},{"date":"2024-09-20","current":-0.107014,"twenty":-7.867968,"median":-0.545154,"eighty":-0.046937,"marketCap":2336274},{"date":"2024-09-27","current":-0.108429,"twenty":-7.867968,"median":-0.494999,"eighty":-0.04713,"marketCap":2367150},{"date":"2024-10-04","current":-0.111201,"twenty":-7.860061,"median":-0.442115,"eighty":-0.047393,"marketCap":2427682},{"date":"2024-10-11","current":-0.11563,"twenty":-7.860061,"median":-0.437694,"eighty":-0.04744,"marketCap":2524360},{"date":"2024-10-18","current":-0.111201,"twenty":-7.860061,"median":-0.431488,"eighty":-0.047955,"marketCap":2427682},{"date":"2024-10-25","current":-0.101853,"twenty":-7.860061,"median":-0.426981,"eighty":-0.048002,"marketCap":2223585},{"date":"2024-10-31","current":-0.098959,"twenty":-7.860061,"median":-0.4229,"eighty":-0.048294,"marketCap":2160422},{"date":"2024-11-08","current":-0.07479,"twenty":-7.860061,"median":-0.412358,"eighty":-0.048539,"marketCap":1632777},{"date":"2024-11-15","current":-0.055601,"twenty":-7.860061,"median":-0.407596,"eighty":-0.048609,"marketCap":1213841},{"date":"2024-11-22","current":-0.057411,"twenty":-7.860061,"median":-0.384846,"eighty":-0.048677,"marketCap":1224583},{"date":"2024-11-29","current":-0.118021,"twenty":-7.860061,"median":-0.371269,"eighty":-0.048708,"marketCap":2517426},{"date":"2024-12-06","current":-0.113252,"twenty":-7.860061,"median":-0.366321,"eighty":-0.048948,"marketCap":2415688},{"date":"2024-12-13","current":-0.118692,"twenty":-7.860061,"median":-0.339908,"eighty":-0.049263,"marketCap":2531726},{"date":"2024-12-20","current":-0.136276,"twenty":-7.860061,"median":-0.332663,"eighty":-0.049654,"marketCap":2906796},{"date":"2024-12-27","current":-0.135177,"twenty":-7.856898,"median":-0.328846,"eighty":-0.049901,"marketCap":2883354},{"date":"2025-01-03","current":-0.119791,"twenty":-7.852153,"median":-0.327576,"eighty":-0.050145,"marketCap":2555168},{"date":"2025-01-10","current":-0.129682,"twenty":-7.852153,"median":-0.324836,"eighty":-0.050769,"marketCap":2766145},{"date":"2025-01-17","current":-0.148365,"twenty":-7.852153,"median":-0.320528,"eighty":-0.050891,"marketCap":3164657},{"date":"2025-01-24","current":-0.165949,"twenty":-7.852153,"median":-0.316323,"eighty":-0.050891,"marketCap":3539728},{"date":"2025-01-31","current":-0.151662,"twenty":-7.852153,"median":-0.310469,"eighty":-0.050903,"marketCap":3234983},{"date":"2025-02-07","current":-0.135726,"twenty":-7.852153,"median":-0.309502,"eighty":-0.051217,"marketCap":2895075},{"date":"2025-02-14","current":-0.14287,"twenty":-7.852153,"median":-0.307568,"eighty":-0.05144,"marketCap":3047448},{"date":"2025-02-21","current":-0.134078,"twenty":-7.852153,"median":-0.304393,"eighty":-0.051476,"marketCap":2859913},{"date":"2025-02-28","current":-0.128583,"twenty":-7.852153,"median":-0.301891,"eighty":-0.051476,"marketCap":2742703},{"date":"2025-03-07","current":-0.097811,"twenty":-7.852153,"median":-0.288309,"eighty":-0.051544,"marketCap":2086329},{"date":"2025-03-14","current":-0.08803,"twenty":-7.852153,"median":-0.285224,"eighty":-0.051753,"marketCap":1877696},{"date":"2025-03-21","current":-0.07704,"twenty":-7.852153,"median":-0.271366,"eighty":-0.051882,"marketCap":1643277},{"date":"2025-03-28","current":-0.076919,"twenty":-7.851441,"median":-0.246413,"eighty":-0.052127,"marketCap":1640699},{"date":"2025-04-04","current":-0.166148,"twenty":-7.850967,"median":-0.166148,"eighty":-0.052638,"marketCap":1564028},{"date":"2025-04-11","current":-0.210427,"twenty":-7.846934,"median":-0.172378,"eighty":-0.052911,"marketCap":1980845},{"date":"2025-04-17","current":-0.194413,"twenty":-7.844246,"median":-0.202243,"eighty":-0.052945,"marketCap":1830092},{"date":"2025-04-25","current":-0.195095,"twenty":-7.844246,"median":-0.193158,"eighty":-0.053044,"marketCap":1836513},{"date":"2025-05-02","current":-0.238005,"twenty":-7.844246,"median":-0.194754,"eighty":-0.053214,"marketCap":2240443},{"date":"2025-05-09","current":-0.219626,"twenty":-7.844246,"median":-0.210427,"eighty":-0.053454,"marketCap":2067433},{"date":"2025-05-16","current":-0.209957,"twenty":-7.844246,"median":-0.210015,"eighty":-0.053777,"marketCap":1856780},{"date":"2025-05-23","current":-0.222112,"twenty":-7.841083,"median":-0.211936,"eighty":-0.054087,"marketCap":1964278},{"date":"2025-05-30","current":-0.26967,"twenty":-7.836338,"median":-0.212746,"eighty":-0.054418,"marketCap":2384859},{"date":"2025-06-06","current":-0.348255,"twenty":-7.836338,"median":-0.216817,"eighty":-0.054599,"marketCap":3079838},{"date":"2025-06-13","current":-0.393217,"twenty":-7.836338,"median":-0.221007,"eighty":-0.054896,"marketCap":3477462},{"date":"2025-06-20","current":-0.372436,"twenty":-7.836338,"median":-0.2251,"eighty":-0.05505,"marketCap":3293684},{"date":"2025-06-27","current":-0.366714,"twenty":-7.836338,"median":-0.232735,"eighty":-0.055459,"marketCap":3243086},{"date":"2025-07-03","current":-0.361641,"twenty":-7.823686,"median":-0.234525,"eighty":-0.055501,"marketCap":3198215},{"date":"2025-07-11","current":-0.325132,"twenty":-7.820523,"median":-0.238005,"eighty":-0.055517,"marketCap":2875343},{"date":"2025-07-16","current":-0.302538,"twenty":-7.733869,"median":-0.246413,"eighty":-0.055543,"marketCap":2675531}],"updateTime":1770585930739},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZVSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588024874","title":"ZyVersa Therapeutics Director Robert Finizio Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2588024874","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588024874?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:16","pubTimestamp":1764796572,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Inc. announced that Robert G. Finizio has resigned from his roles as independent director, Chairman of the Compensation Committee, and member of the Audit Committee, effective immediately. His departure was due to personal reasons and not related to any disagreements with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyversa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL1z9THb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2584975279","title":"ZyVersa Therapeutics posts $20.7 million pre-tax loss for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584975279","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584975279?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:20","pubTimestamp":1763587217,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics reported a pre-tax loss of $20.7 million for the third quarter ended September 30, 2025, compared to a pre-tax loss of $2.4 million for the same period in 2024. The increase in losses was primarily due to an $18.6 million impairment of research and development, related to a decline in market capitalization and uncertainty around financing research milestones. Cash on hand as of September 30, 2025, was $0.5 million. ZyVersa raised approximately $2.1 million in the third quarter and $4.1 million year-to-date. The company is advancing its pipeline, including VAR 200 for kidney diseases and IC 100 for chronic inflammatory diseases, and is seeking additional financing to support ongoing operations and development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL1pNQjy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","NDAQ","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2095319765.USD","ZVSA","IE00BKPKM429.USD","BK4588","LU0314104364.USD"],"gpt_icon":0},{"id":"2584757249","title":"ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2584757249","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584757249?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:20","pubTimestamp":1763587200,"startTime":"0","endTime":"0","summary":"ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3191443/0/en/ZyVersa-Therapeutics-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVSA","FSGS","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2583682087","title":"Zyversa Therapeutics Delays Quarterly Financial Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583682087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583682087?lang=en_us&edition=fundamental","pubTime":"2025-11-15 06:02","pubTimestamp":1763157723,"startTime":"0","endTime":"0","summary":"Zyversa Therapeutics Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company cited the need for additional time to complete management's review of its consolidated financial statements and related disclosures. Zyversa expects to file the report within the five-day extension period provided under SEC rules.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyversa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL2V4RXk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2566860614","title":"ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2566860614","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566860614?lang=en_us&edition=fundamental","pubTime":"2025-09-10 19:55","pubTimestamp":1757505300,"startTime":"0","endTime":"0","summary":"Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/10/3147676/0/en/ZyVersa-Therapeutics-Highlights-Data-Reinforcing-the-Potential-of-Inflammasome-Inhibitors-to-Attenuate-Progression-of-Type-2-Diabetes-and-Improve-Associated-Long-term-Cardiovascula.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","ZVSA","BK4007","BK4539","BK4082","CSII"],"gpt_icon":0},{"id":"2564393460","title":"ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression","url":"https://stock-news.laohu8.com/highlight/detail?id=2564393460","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564393460?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:55","pubTimestamp":1756900500,"startTime":"0","endTime":"0","summary":"ZyVersa is developing Cholesterol Efflux MediatorVAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys’ filtration system. VAR 200 directly removes lipids from ki","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/03/3143489/0/en/ZyVersa-Therapeutics-Highlights-Lipidomic-Data-in-Alport-Syndrome-and-DKD-Reinforcing-the-Need-for-Drugs-to-Attenuate-Damaging-Renal-Lipid-Accumulation-to-Mitigate-Disease-Progress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FSGS","ZVSA","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2559798602","title":"Zyversa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-Term Value-Building Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2559798602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559798602?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:00","pubTimestamp":1755090003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUAC2W6HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2559078726","title":"ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2559078726","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559078726?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:00","pubTimestamp":1755090000,"startTime":"0","endTime":"0","summary":"KEY HIGHLIGHTS First clinical site for Phase 2a clinical trial for Cholesterol Efflux MediatorVAR 200 in patients with diabetic kidney disease (DKD) was activated June 2025; patient screening is under","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132643/0/en/ZyVersa-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Highlights-Key-Near-term-Value-building-Milestones.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ZVSA","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2554779315","title":"ZyVersa Therapeutics Inc. Secures Approval for OTCQB Listing, Set to Begin Trading on July 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779315?lang=en_us&edition=fundamental","pubTime":"2025-07-28 19:56","pubTimestamp":1753703790,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Inc. has announced that its common stock has been approved for quotation on the OTCQB Venture Market. Trading is set to begin on July 28, 2025, under the ticker symbol \"ZVSA.\". Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyversa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL5J3fLg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2552124745","title":"Zyversa Therapeutics Faces Nasdaq Delisting Due to Failure to Meet Minimum Bid Price Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552124745?lang=en_us&edition=fundamental","pubTime":"2025-07-17 00:41","pubTimestamp":1752684084,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Inc. has announced that it received a determination letter from The Nasdaq Stock Market LLC indicating the denial of its request to continue listing on The Nasdaq Capital Market. This decision follows the company's non-compliance with the minimum bid price requirements under Nasdaq's Listing Rule 5550. Despite appealing the decision and requesting an exception to complete its compliance plan, the Nasdaq Hearings Panel upheld the delisting decision. Consequently, trading of ZyVersa's common stock will be suspended at the opening of trading on July 17, 2025. The company plans to mitigate the impact by applying for trading on the Pink Limited Market under the symbol \"ZVSA.\" This move might pose challenges for stockholders due to a potentially limited market for trading shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDLKjgSw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2550966335","title":"Zyversa Therapeutics Inc. Enters Warrant Exercise Inducement Agreement for 3.06M Shares, Plans to Register Inducement Warrant Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966335","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966335?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:16","pubTimestamp":1752092184,"startTime":"0","endTime":"0","summary":"Zyversa Therapeutics Inc. Enters Warrant Exercise Inducement Agreement for 3.06M Shares, Plans to Register Inducement Warrant Shares. On July 8, 2025, Zyversa Therapeutics Inc. entered into a warrant exercise inducement offer agreement with a holder of Series A-2 and A-3 Common Stock purchase warrants. The holder agreed to exercise the existing warrants, originally issued on November 5, 2024, and March 5, 2025, for a reduced price of $0.67 per share, down from $1.00. This involves up to 957,200 shares from Series A-2 Warrants and 2,105,265 shares from Series A-3 Warrants. Zyversa will issue new Series A-4 warrants for up to 6,124,930 shares at $0.67 each, exercisable over five years from the stockholder approval date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL6qyKYm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2546248130","title":"ZyVersa Therapeutics Initiates New Clinical Study for Cholesterol Efflux Mediator VAR 200 to Combat Chronic Kidney Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2546248130","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546248130?lang=en_us&edition=fundamental","pubTime":"2025-06-25 21:01","pubTimestamp":1750856501,"startTime":"0","endTime":"0","summary":"ZyVersa Therapeutics Inc., a clinical stage specialty biopharmaceutical company, has announced a share purchase agreement with Williamsburg Venture Holdings to fund the clinical development of their Cholesterol Efflux MediatorTM VAR 200 for treating chronic kidney diseases. The agreement allows ZyVersa to sell up to $10 million worth of common stock over a 24-month period, with Williamsburg Venture Holdings obligated to purchase these shares at a discounted market price. This partnership aims to provide ZyVersa with a flexible source of funding to advance the clinical development of VAR 200. The company plans to use the share purchase agreement strategically to achieve key development milestones while minimizing shareholder dilution. There are no warrants or derivatives associated with the agreement, and ZyVersa retains control over the timing and amount of stock sales. The results of the clinical development are not yet presented.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL73MfvV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0},{"id":"2546212048","title":"BRIEF-ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2546212048","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546212048?lang=en_us&edition=fundamental","pubTime":"2025-06-25 19:56","pubTimestamp":1750852591,"startTime":"0","endTime":"0","summary":"BRIEF-ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 MillionJune 25 (Reuters) - Zyversa Therapeutics Inc ZVSA.O:ZYVERSA THERAPEUTICS ANNOUNCES SHARE PURCHASE AGREEMENT FOR UP TO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nTUABQ5XPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZVSA"],"gpt_icon":0},{"id":"2543419547","title":"Zyversa Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543419547","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543419547?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:47","pubTimestamp":1749761272,"startTime":"0","endTime":"0","summary":"Zyversa Therapeutics Inc. held its annual meeting of stockholders on June 11, 2025. During the meeting, stockholders elected Stephen C. Glover and Robert G. Finizio as Class III directors. Additionally, stockholders ratified the selection of CBIZ CPAs, P.C. as the independent registered public accounting firm for the year ending December 31, 2025. The Amended and Restated Equity Incentive Plan, which increases the number of shares of common stock reserved for issuance, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyversa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL89VYvz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVSA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}